Patent · US Active

Monoamine reuptake inhibitors

US9562001B2 · kind B2 · utility

0Cited by

8References

5Claims

0Family size

Assignee

Research Triangle Institute · US

Inventors

Frank Ivy Carroll · Durham, US
Bruce E. Blough · Raleigh, US
Philip Abraham · Cary, US

Key dates

Filing date	Oct 12, 2011
Grant date	Feb 7, 2017
Priority date	—
Expiry date	Oct 12, 2031

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07C2601/14
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention provides bupropion analog compounds capable of inhibiting the reuptake of one or more monoamines. The compounds may selectively bind to one or more monoamine transporters, including those for dopamine, norepinephrine, and serotonin. Such compounds may be used to treat conditions that are responsive to inhibition of the reuptake of monoamines, including addiction, depression, and obesity.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.